Montag A & Associates Inc. Decreases Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Montag A & Associates Inc. lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 16.5% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 16,429 shares of the medical equipment provider’s stock after selling 3,235 shares during the quarter. Montag A & Associates Inc.’s holdings in Intuitive Surgical were worth $8,575,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Aveo Capital Partners LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $276,000. Empire Life Investments Inc. acquired a new position in Intuitive Surgical in the 4th quarter valued at $2,529,000. Nations Financial Group Inc. IA ADV lifted its holdings in Intuitive Surgical by 5.5% in the 4th quarter. Nations Financial Group Inc. IA ADV now owns 829 shares of the medical equipment provider’s stock valued at $433,000 after purchasing an additional 43 shares in the last quarter. Spinnaker Trust acquired a new stake in Intuitive Surgical during the 4th quarter worth $201,000. Finally, Center for Financial Planning Inc. grew its holdings in shares of Intuitive Surgical by 77.5% during the fourth quarter. Center for Financial Planning Inc. now owns 458 shares of the medical equipment provider’s stock worth $239,000 after buying an additional 200 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Up 0.7 %

NASDAQ:ISRG opened at $595.55 on Friday. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The stock’s fifty day moving average is $559.48 and its two-hundred day moving average is $519.06. The stock has a market capitalization of $212.12 billion, a price-to-earnings ratio of 92.91, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. CICC Research began coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 price target on the stock. Royal Bank of Canada boosted their target price on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Evercore ISI increased their price target on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Bernstein Bank boosted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. Finally, Wells Fargo & Company raised their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $613.10.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 269 shares of the stock in a transaction on Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the sale, the chief financial officer now owns 3,282 shares in the company, valued at approximately $1,936,380. The trade was a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 6,348 shares of company stock valued at $3,587,582. Corporate insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.